Inventor · disambiguated record
Chingwei V. Lee
Also filed as: LEE CHINGWEI V · LEE CHINGWEI VIVIAN
21 granted patents·11 pending applications·109 citations·filing 2004–2025
94Inventor score
Top patents by PatentIndex Score
32 records- 0195US11891437B2Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymerGENENTECH INC·Filed 2021·Granted Feb 6, 2024·3 cites·22 claims
- 0294US11007267B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2017·Granted May 18, 2021·8 cites·27 claims
- 0394US7910098B2Anti-VEGF antibodiesGENENTECH INC·Filed 2008·Granted Mar 22, 2011·27 cites·19 claims
- 0493US10072075B2Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesisGENENTECH INC·Filed 2016·Granted Sep 11, 2018·17 cites·48 claims
- 0592US11111291B2Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymerGENENTECH INC·Filed 2019·Granted Sep 7, 2021·6 cites·41 claims
- 0691US10899828B2Optimized variants of anti-vegf antibodies and methods of use thereof in treatmentGENENTECH INC·Filed 2018·Granted Jan 26, 2021·5 cites·52 claims
- 0791US10421822B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 24, 2019·4 cites·52 claims
- 0888US2025109195A1Dual specific antibodiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 0988US2025346661A1Dual specific antibodiesGENENTECH INC·Filed 2025·Application pending·0 cites
- 1087US10683348B2Dual specific antibodiesGENENTECH INC·Filed 2016·Granted Jun 16, 2020·3 cites·15 claims
- 1186US10906968B2Polynucleotides encoding optimized variants of anti-VEGF antibodiesGENENTECH INC·Filed 2018·Granted Feb 2, 2021·2 cites·33 claims
- 1286US8486397B2Anti-VEGF-C antibodies and methods using sameBAGRI ANIL D·Filed 2010·Granted Jul 16, 2013·11 cites·8 claims
- 1386US2024067752A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2023·Application pending·0 cites
- 1486US2024279327A1Dual specific antibodiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 1585US10421821B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 24, 2019·2 cites·44 claims
- 1683US11512143B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2019·Granted Nov 29, 2022·1 cites·21 claims
- 1782US2023383008A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2022·Application pending·0 cites
- 1881US8921537B2Anti-VEGF antibodiesFUH GERMAINE·Filed 2011·Granted Dec 30, 2014·4 cites·21 claims
- 1978US7799899B2Compositions and methods relating to STOP-1GENENTECH INC·Filed 2004·Granted Sep 21, 2010·14 cites·19 claims
- 2076US9102720B2Anti-VEGF-C antibodies and methods using sameGENENTECH INC·Filed 2013·Granted Aug 11, 2015·1 cites·40 claims
- 2173US12121586B2Optimized variants of anti-VEGF antibodiesGENENTECH INC·Filed 2020·Granted Oct 22, 2024·0 cites·20 claims
- 2273US9777059B2Anti-VEGF antibodiesGENENTECH INC·Filed 2014·Granted Oct 3, 2017·1 cites·12 claims
- 2372US12006360B2Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)GENENTECH INC·Filed 2020·Granted Jun 11, 2024·0 cites·11 claims
- 2471US12365732B2Anti-CD96 antibodies and methods of use thereof23ANDME INC·Filed 2022·Granted Jul 22, 2025·0 cites·24 claims
- 2567US2024132582A1Anti-il-36 antibodies and methods of use thereof23ANDME INC·Filed 2023·Application pending·0 cites
- 2664US11555073B2Anti-CD96 antibodies and methods of use thereof23ANDME INC·Filed 2019·Granted Jan 17, 2023·0 cites·28 claims
- 2764US2021244815A1Anti-cd3 antibodies and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 2856US11884719B2Anti-IL-36 antibodies and methods of use thereof23ANDME INC·Filed 2019·Granted Jan 30, 2024·0 cites·23 claims
- 2948US2010166741A1Altered br-3 binding polypeptidesGENENTECH INC·Filed 2007·Application pending·0 cites
- 3045US2008181888A1Polypeptides That Bind Br3 and Uses ThereofAMBROSE CHRISTINE M·Filed 2005·Application pending·0 cites
- 3143US2010280227A1Polypeptides that bind br3 and uses thereofGENENTECH INC·Filed 2010·Application pending·0 cites
- 3239US2011112279A1Compositions and Methods Relating to STOP-1GENENTECH INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chingwei V. Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →